Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Net Debt / EBITDA

Aquestive Therapeutics Inc Net Debt / EBITDA Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Net Debt / EBITDA from 2017 to 2018. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Aquestive Therapeutics Inc Net Debt / EBITDA for the quarter ending March 03, 2018 was $1m
  • Aquestive Therapeutics Inc Net Debt / EBITDA for the last 12 months ending March 03, 2018 was $4m
  • Aquestive Therapeutics Inc Annual Net Debt / EBITDA for 2017 was $7m a -26.56% decrease of -2m from 2016
  • Aquestive Therapeutics Inc Annual Net Debt / EBITDA for 2016 was $9m
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST Net Debt / EBITDA Data

03/2018$1m
03/2017$4m

Annual AQST Net Debt / EBITDA Data

2017$7m
2016$9m